<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>NIGMS - What's New</title>
    <link>http://www.nigms.nih.gov</link>
    <description>Supporting research that is the foundation for disease diagnosis, treatment, and prevention. One of the U.S. National Institutes of Health.</description>
    <generator>NIH CMS RSS feeder 2.0</generator>
    <item>
      <title>Predicting Side Effects and Repurposing Drugs</title>
      <link>http://www.nigms.nih.gov/News/Results/predict_sideeffects.htm</link>
      <pubDate>Tue, 24 Nov 2009 16:59:40 EST</pubDate>
      <guid isPermaLink="false">{C27600EC-F0CA-4BF4-A9DD-0F097346C482}</guid>
      <description>A team of NIGMS-supported pharmaceutical chemists has devised a method for predicting a drug's close contacts inside the body, providing a new way to identify unwanted interactions and novel therapeutic targets.</description>
    </item>
    <item>
      <title>NIGMS Invests in Scientific Grand Opportunities with Recovery Act Funds</title>
      <link>http://www.nigms.nih.gov/News/Results/gogrant_112309.htm</link>
      <pubDate>Mon, 23 Nov 2009 08:28:37 EST</pubDate>
      <guid isPermaLink="false">{1C5D18EA-6B4B-4EC7-B3BA-9A7591B1A793}</guid>
      <description>NIGMS has invested $42.3 million of Recovery Act funds to launch 14 “Grand Opportunity” research projects that address critical gaps in the basic biomedical sciences.</description>
    </item>
    <item>
      <title>NIGMS ‘Challenge’ Areas Get Millions in Recovery Act Funds</title>
      <link>http://www.nigms.nih.gov/News/Results/20091119.htm</link>
      <pubDate>Thu, 19 Nov 2009 10:00:41 EST</pubDate>
      <guid isPermaLink="false">{452CFB98-41AD-46D2-9826-BEE1B0EAF915}</guid>
      <description>NIGMS has invested $16.4 million of Recovery Act funds to jump-start a range of two-year research projects that address critical gaps in the basic biomedical and behavioral sciences.</description>
    </item>
    <item>
      <title>2010 NIH Director’s New Innovator Award Program (DP2)</title>
      <link>http://www.nigms.nih.gov/Research/Funding/RFAs/RFA-RM-09-011.htm</link>
      <pubDate>Mon, 16 Nov 2009 12:19:25 EST</pubDate>
      <guid isPermaLink="false">{C8DA016D-14EB-4618-97CF-EABB36A0869F}</guid>
      <description />
    </item>
    <item>
      <title>Could Genetics Improve Warfarin Dosing?</title>
      <link>http://www.nigms.nih.gov/News/Results/Warfarin02182009.htm</link>
      <pubDate>Thu, 5 Nov 2009 12:25:53 EST</pubDate>
      <guid isPermaLink="false">{C9F10617-B9FC-442A-B747-24BFDF663917}</guid>
      <description>A world wide team of researchers used computer modeling to address one of the trickiest drugs to prescribe—the blood-thinner warfarin. To test the gene-based strategy in patients, NIH is launching a large-scale clinical trial.</description>
    </item>
    <item>
      <title>Minority Programs</title>
      <link>http://www.nigms.nih.gov/Minority/default.htm</link>
      <pubDate>Tue, 3 Nov 2009 14:28:09 EST</pubDate>
      <guid isPermaLink="false">{166DC26A-3893-4BDF-9D62-1016374FDF0A}</guid>
      <description />
    </item>
  </channel>
</rss>